Pathfinder Cell Therapy (PFND) Short Interest Ratio & Short Volume → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free PFND Stock Alerts Add Compare Share Share Short InterestStock AnalysisChartStock AnalysisChart Pathfinder Cell Therapy Short Interest DataCurrent Short Volume2,100 sharesPrevious Short Volume14,300 sharesChange Vs. Previous Month-85.31%Dollar Volume Sold Short$6.30Short Interest Ratio / Days to Cover0.0Last Record DateJuly 30, 2021Today's Trading Volume0 sharesAverage Trading Volume0 sharesToday's Volume Vs. AverageNaN Short Selling Pathfinder Cell Therapy ? Sign up to receive the latest short interest report for Pathfinder Cell Therapy and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPFND Short Interest Over TimePFND Days to Cover Over TimePFND Percentage of Float Shorted Over Time Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> Pathfinder Cell Therapy Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/30/20212,100 shares $6.30 -85.3%N/A0 $0.00 7/15/202114,300 shares $137.28 No ChangeN/A0.1 $0.01 6/30/202114,300 shares $143.00 No ChangeN/A0.1 $0.01 5/14/202177,200 shares $648.48 -5.9%N/A51.5 $0.01 4/30/202182,000 shares $803.60 +4,000.0%N/A1.4 $0.01 4/15/20212,000 shares $16.00 No ChangeN/A0 $0.01 2/26/202117,300 shares $242.20 No ChangeN/A0.3 $0.01 1/29/20219,600 shares $158.88 No ChangeN/A0.1 $0.02 PFND Short Interest - Frequently Asked Questions What is Pathfinder Cell Therapy's current short interest? Short interest is the volume of Pathfinder Cell Therapy shares that have been sold short but have not yet been closed out or covered. As of July 30th, traders have sold 2,100 shares of PFND short. Learn More on Pathfinder Cell Therapy's current short interest. Is Pathfinder Cell Therapy's short interest increasing or decreasing? Pathfinder Cell Therapy saw a drop in short interest in July. As of July 30th, there was short interest totaling 2,100 shares, a drop of 85.3% from the previous total of 14,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Pathfinder Cell Therapy's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Pathfinder Cell Therapy: Shandong Weigao Group Medical Polymer Company Limited (0.88%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($9.46 billion), Block, Inc. ($7.91 billion), S&P Global Inc. ($7.79 billion), Analog Devices, Inc. ($7.10 billion), Moderna, Inc. ($6.65 billion), Aon plc ($5.10 billion), Charter Communications, Inc. ($5.09 billion), Wayfair Inc. ($3.82 billion), Teladoc Health, Inc. ($2.64 billion), and Nuance Communications, Inc. ($2.45 billion). View all of the most shorted stocks. What does it mean to sell short Pathfinder Cell Therapy stock? Short selling PFND is an investing strategy that aims to generate trading profit from Pathfinder Cell Therapy as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Pathfinder Cell Therapy? A short squeeze for Pathfinder Cell Therapy occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PFND, which in turn drives the price of the stock up even further. How often is Pathfinder Cell Therapy's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PFND, twice per month. The most recent reporting period available is July, 30 2021. More Short Interest Resources from MarketBeat Related Companies: Coloplast A/S Short Interest Data Shandong Weigao Group Medical Polymer Short Interest Data 180 Life Sciences Short Interest Data 1933 Industries Short Interest Data 3SBio Short Interest Data 4Cable TV International Short Interest Data 4Front Ventures Short Interest Data AB Science Short Interest Data Abcam Short Interest Data Abliva AB (publ) Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:PFND) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics